San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion ...
Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven ...
Devyser today announced that it entered a strategic agreement with Illumina, a global leader in DNA sequencing and array-based technologies, to provide Illumina sequencing instruments and related prod ...
Deeply expands leadership in proteomics and multiomicsCombined capabilities bring high scalability, flexibility, and affordability into protein analysis Combination leverages SomaScan with Illumina's ...
What Is Driving the Updated Illumina Price Target? Illumina's fair value estimate has been revised from about US$119.84 to ...
Researchers are now exploring how to best extract and use saliva-derived DNA for long-read sequencing applications. Download ...
Illumina shares edge down 3.5% in premarket trading after China placed restrictions on the company as it caught itself in the country's crosshairs in response to a developing trade war. Shares were ...
Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results